236 related articles for article (PubMed ID: 24842407)
1. Proton therapy for Hodgkin lymphoma.
Rutenberg MS; Flampouri S; Hoppe BS
Curr Hematol Malig Rep; 2014 Sep; 9(3):203-11. PubMed ID: 24842407
[TBL] [Abstract][Full Text] [Related]
2. Proton therapy in the management of lymphoma.
Ho CK; Flampouri S; Hoppe BS
Cancer J; 2014; 20(6):387-92. PubMed ID: 25415683
[TBL] [Abstract][Full Text] [Related]
3. Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.
Hoppe BS; Flampouri S; Zaiden R; Slayton W; Sandler E; Ozdemir S; Dang NH; Lynch JW; Li Z; Morris CG; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1053-1059. PubMed ID: 24928256
[TBL] [Abstract][Full Text] [Related]
4. Future perspectives of radiation therapy for Hodgkin Lymphoma: Risk-adapted, response-adapted, and safer than before.
Saddi J; Barcellini A; Gotti M; Mazzacane A; Tolva A; Lazic T; Arcaini L; Zecca M; Orlandi E; Filippi AR
Hematol Oncol; 2024 May; 42(3):e3269. PubMed ID: 38650534
[TBL] [Abstract][Full Text] [Related]
5. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
[TBL] [Abstract][Full Text] [Related]
6. Late complications of Hodgkin's disease management.
Young RC; Bookman MA; Longo DL
J Natl Cancer Inst Monogr; 1990; (10):55-60. PubMed ID: 2189477
[TBL] [Abstract][Full Text] [Related]
7. Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison.
König L; Bougatf N; Hörner-Rieber J; Chaudhri N; Mielke T; Klüter S; Haefner MF; Rieken S; Haberer T; Debus J; Herfarth K
Strahlenther Onkol; 2019 Jul; 195(7):677-687. PubMed ID: 30972453
[TBL] [Abstract][Full Text] [Related]
8. Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin's disease.
Lautenschlaeger S; Iancu G; Flatten V; Baumann K; Thiemer M; Dumke C; Zink K; Hauswald H; Vordermark D; Mauz-Körholz C; Engenhart-Cabillic R; Eberle F
Radiat Oncol; 2019 Sep; 14(1):157. PubMed ID: 31477141
[TBL] [Abstract][Full Text] [Related]
9. Concomitant illness in patients treated for Hodgkin's disease.
Bookman MA; Longo DL
Cancer Treat Rev; 1986 Jun; 13(2):77-111. PubMed ID: 3527412
[No Abstract] [Full Text] [Related]
10. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
[TBL] [Abstract][Full Text] [Related]
11. Proton therapy in a pediatric patient with stage III Hodgkin lymphoma.
Holtzman A; Flampouri S; Li Z; Mendenhall NP; Hoppe BS
Acta Oncol; 2013 Apr; 52(3):592-4. PubMed ID: 23477362
[No Abstract] [Full Text] [Related]
12. Late complications after treatment for Hodgkin lymphoma.
Ng AK
Curr Hematol Malig Rep; 2008 Jul; 3(3):119-25. PubMed ID: 20425456
[TBL] [Abstract][Full Text] [Related]
13. Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry.
Hoppe BS; Tsai H; Larson G; Laramore GE; Vargas C; Tseng YD; Dunn M; McGee L; Cahlon O; Hartsell W
Acta Oncol; 2016 Nov; 55(11):1378-1380. PubMed ID: 27579554
[No Abstract] [Full Text] [Related]
14. Radiation Therapy for Treatment of Adolescent and Young Adult Hodgkin Lymphoma and Risk for Cardiovascular Disease and Cancer.
Rugbjerg K; Olsen JH
J Adolesc Young Adult Oncol; 2019 Feb; 8(1):1-8. PubMed ID: 30192163
[TBL] [Abstract][Full Text] [Related]
15. Proton Therapy for Pediatric Hodgkin Lymphoma.
Wray J; Flampouri S; Slayton W; Joyce M; Sandler E; Morris CG; Li Z; Indelicato DJ; Mendenhall NP; Hoppe BS
Pediatr Blood Cancer; 2016 Sep; 63(9):1522-6. PubMed ID: 27149120
[TBL] [Abstract][Full Text] [Related]
16. Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?
Knäusl B; Lütgendorf-Caucig C; Hopfgartner J; Dieckmann K; Kurch L; Pelz T; Pötter R; Georg D
Strahlenther Onkol; 2013 Jan; 189(1):54-61. PubMed ID: 23161118
[TBL] [Abstract][Full Text] [Related]
17. Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experience.
Loap P; Goudjil F; Dendale R; Kirova Y
Cancer Radiother; 2021 Dec; 25(8):779-785. PubMed ID: 34275748
[TBL] [Abstract][Full Text] [Related]
18. Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy.
Hoppe BS; Flampouri S; Lynch J; Slayton W; Zaiden R; Li Z; Mendenhall NP
Oncology (Williston Park); 2012 May; 26(5):456-9, 462-5. PubMed ID: 22730602
[TBL] [Abstract][Full Text] [Related]
19. Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma.
Darrington DL; Vose JM
Curr Hematol Malig Rep; 2012 Sep; 7(3):200-7. PubMed ID: 22743837
[TBL] [Abstract][Full Text] [Related]
20. Late effects of Hodgkin's disease and its treatment.
Ng AK; Mauch PM
Cancer J; 2009; 15(2):164-8. PubMed ID: 19390314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]